INTRODUCTION
============

Seaweeds are categorized as brown algae, red algae, and green algae, and domestic seaweeds contain 6--42% of proteins and 6--74% of carbohydrates with some variation \[[@B1][@B2]\]. Sea algae also contain a variety of bioactive substances such as polyphenols, polysaccharides, minerals and amino acids. Especially, red algae are well-known for their biological activities including antibacterial, anti-oxidant, and anti-asthmatic effects \[[@B3][@B4][@B5][@B6]\]. Red algae are composed of approximately 40--75% carbohydrate based on their dry weight, and the majority components are cellulose, xylan, mannan, and agar \[[@B7]\]. Among them, *Gelidium amansii* (*GA*) contains plenty of agars, which make them a popular functional food for reducing body weight. Also, *GA* has been reported to have various bioactive properties such as antioxidant, anti-inflammatory, anti-diabetic, anti-obesity and anti-atherogenic effects \[[@B8][@B9][@B10]\].

A recent study reported a decrease of paraepididymal and perirenal fat tissues, blood triglyceride, and inflammatory cytokines such as adipocytokines, tumor necrosis factor (TNF)-α and interleukin (IL)-6 in rats fed high-fat diet (HFD) + *GA* for 11 wks \[[@B11]\]. Also, agar consumption to diabetic patients to reduce hunger sensation had a cholesterol-lowering effect as well as reducing blood glucose levels and fat mass \[[@B12]\]. *GA* extract reduced mRNA expression of NADPH oxidase 4 (NOX4) and a reactive oxygen species (ROS) marker while it increased antioxidant enzymes protein expressions such as superoxide dismutase (SOD) 1/2, glutathione peroxidase (GPx), and glutathione reductase (GR) in fully differentiated 3T3-L1 adipocytes \[[@B10]\].

Previously, other studies have demonstrated an anti-inflammatory effect of *GA*-ethanol extracts in *in vitro* model by using mouse preadipocytes or *in vivo* mouse model \[[@B8][@B13][@B14]\]. Collectively, various studies have shown that agar in *GA* may have anti-obesity effects; however, it is not clear yet whether the bioactive properties of *GA* extract (*GAE*) are due to agar itself or not. In this study, we investigated potential health-beneficial effects of *GAE* without agar, *AfGAE*, in diet-induced obese (DIO) C57BL/6J mouse model. Initially, anti-obesity effects of *AfGAE* were examined in HFD-induced obese mouse model as a pilot study. With anti-inflammatory and lipolytic effects of *GAE* without agar observed in the pilot study, further studies were carried out to compare the preventive model vs treatable model with various doses of *GAE* without agar in C57BL/6J mice.

MATERIALS AND METHODS
=====================

Preparation of Gelidium amansii extracts (GAE)
----------------------------------------------

*Gelidium amansii* (*GA*) was obtained from Seojin Biotech Co Ltd. (Yongin-si, Gyounggi-do, Republic of Korea). The dried *Gelidium amansii* (*GA*) powder (30 g) was extracted using 100 mL of 70% aqueous ethanol. Extracts were evaporated and dissolved in dimethyl sulfoxide (30 mg/mL). Extraction of *GA* was processed per a protocol published \[[@B15]\]. Components of *GAE* were analyzed in Korea Health Supplement Institute (KHSI, Seongnam-si, Gyeonggi-do, Republic of Korea) ([Table 1](#T1){ref-type="table"}). To eliminate a major high-molecular oligosaccharide, agar, from *GAE*, it was treated with 0.1 N HCL and then autoclaved at 120℃ for 15 mins. Residual substance was removed by centrifugation at 150 rpm for 1 hr, and the prepared *AfGAE* was quantified \[[@B1][@B16]\].

Experimental design
-------------------

Male C57BL/6J mice (30--34 g) at 8 wks of age were purchased from Orient Bio Co. (Seongnam-si, Gyeonggi-do, Republic of Korea) and housed individually at the Center of Animal Care and Use of the Cancer and Diabetes institute in Gachon University. Animals were maintained in a temperature (21 ± 2℃) and humidity (50 ± 20%) controlled room with a 12 hr dark-light cycle. Ethical treatment of animals was assured by the CACU Institutional Animal Care and Use Committee (\#LCDI-2014-0071) in Gachon University. Design for animal experiments is shown in [Fig. 1](#F1){ref-type="fig"}. In *pilot* experiments, mice were acclimated to oral administration and fed with 60% calories from fat, (HFD, Research Diet D12492, NJ, USA) or HFD + agar-free *GAE* (*AfGAE*, 250 mg/kg of body weight) for 8 wks (n = 5/group). *AfGAE* was further studied in prevention and treatment ([Fig. 1](#F1){ref-type="fig"}, *Experiment* *(Exp)-1* and *Exp-2*). For *Exp-1*, a preventive model, male 8-wk old C57BL/6J mice were stabilized and acclimatized for oral administration, followed by oral administration of different doses of *AfGAE* (0, 250, 300, 500, 1,000 mg/kg of body weight, n = 5/group) with HFD for 8 wks. For *Exp-2*, a treatment model, male 8-wk old C57BL/6J mice were stabilized for 1 wk, followed by 5 wks of DIO induction by HFD including the acclimation period of oral administration, and then fed different doses of *AfGAE* (0, 250, 300, 500, 1,000 mg/kg of body weight, n = 5/group) for 8 wks.

Plasma lipid and insulin levles
-------------------------------

Total triglyceride (TG) and cholesterol (TC) levels in plasma were determined using commercial assay kits (Asan Pharm., Seoul, Republic of Korea) according to the manufacturer\'s instructions. Mouse insulin in plasma was measured by mouse ELISA kits (Thermo Scientific, Fredrick, MD, USA) according to the manufacturer\'s instructions. All samples and standards were measured in duplicate.

Western blotting analysis
-------------------------

Protein from frozen epididymal and mesenteric fat tissues were isolated by using lysis buffer (Cell signaling, Boston, MA, USA) and immediately homogenized as previously described \[[@B17]\]. Proteins (30--35 µg) were separated by 8% to 15% SDS-PAGE gel, and transferred to nitrocellulose membrane and incubated with the indicated antibody and horseradish peroxidase-coupled anti-species antibodies. Proteins were visualized by Bio-Rad chemiluminescence system. Concentrations of antibodies used in this study are as follows; p-HSL (1:1000), acetyl CoA carboxylase (ACC, 1:1000), Adiponectin (1:1000), IL-10 (1:1000), β-actin (1:5,000), GAPDH (1:5,000). Antibodies for hormone sensitive lipase (HSL), p-HSL, adiponectin, β-actin, and GAPDH were purchased from Cell Signaling (Danvers, MA, USA). The antibodies for total ACC and IL-10 were obtained from Abcam (Cambridge, MA, USA).

Statistical analysis
--------------------

Data are presented as mean ± standard deviation (SD). Statistical difference was determined by the t-test or one-way ANOVA (one-way analysis of variance) followed by Tukey\'s multiple comparison test by using SPSS 12.0 (SPSS Inc, Chicago, IL, USA). Significance was set at a *P*-value \< 0.05.

RESULTS
=======

AfGAE improved HFD-induced inflammation and lipolysis related factors
---------------------------------------------------------------------

Comparison of metabolic parameters in mice fed HFD or HFD + *AfGAE* for 8 wks in the *pilot study* are shown in [Table 2](#T2){ref-type="table"}. Mice fed HFD + *AfGAE* had a similar weight gain to the mice fed HFD suggesting no anti-obesity effects of *AfGAE* oral administration to HFD fed C57BL/6J mice. In addition, food efficiency ratio (FER) was significantly increased in mice fed HFD + *AfGAE* compared to mice fed HFD only. Total fat mass and brown adipose tissue (BAT) in mice fed HFD + *AfGAE* seemed to be slightly higher than that in HFD group, but that did not reach statistical significance. Plasma analysis results showed insulin levels were significantly increased in mice fed HFD + *AfGAE* compared to mice fed HFD. However, there were no significant differences in TG and TC levels in plasma between HFD and HFD + *AfGAE*.

We further observed alterations of lipolysis related proteins such as total acetyl CoA carboxylase (ACC), total hormone-sensitive lipase (HSL) and p-HSL expression in adipose tissue from the HFD group and HFD + *AfGAE* group ([Fig. 2](#F2){ref-type="fig"}). No significant difference was detected in ACC protein expression in the mesenteric fat pad between the HFD group and HFD + *AfGAE* group, meanwhile phosphorylation levels of HSL were significantly upregulated in mesenteric fat pad of mice fed HFD + *AfGAE* compared to that of mice fed HFD only (*P* \< 0.01). Furthermore, expression of IL-10, an anti-inflammatory cytokine, was significantly increased in epididymal fat pad of the HFD + *AfGAE* group compared to that of the HFD group whereas no difference was observed in expression of adiponectin ([Fig. 2](#F2){ref-type="fig"}). Next, we focused on the effects of HFD + *AfGAE* administration on the inflammatory in a preventive model (*Exp-1*) and treatment model (*Exp-2*) to find out an optimal concentration and proper approach strategy of *AfGAE* to induce potential health beneficial effects in DIO model.

AfGAE administration enhanced expression of lipolysis related proteins
----------------------------------------------------------------------

We further investigated effects of various doses of *AfGAE* (0, 250, 300, 500, 1,000 mg/kg) in a DIO mouse model as a prevention ([Fig. 3](#F3){ref-type="fig"}) and treatment model ([Fig. 4](#F4){ref-type="fig"}). Weight changes of BAT were not different among five groups in two models ([Fig. 3](#F3){ref-type="fig"} & [4](#F4){ref-type="fig"}, Panel B). Fat/muscle ratio (FMR, retro-peritoneal fat/quadriceps) also showed no significant difference among the groups ([Fig. 3](#F3){ref-type="fig"} & [4](#F4){ref-type="fig"}, Panel C). Despite no improvement in body weight and organ weight changes by various doses of *AfGAE* administration in two models, HSL phosphorylation was significantly increased by *AfGAE* administration up to 500 mg/kg in mesenteric adipose tissue of a preventive model dose-dependently except the highest concentration of *AfGAE* (1,000 mg/kg) treated group ([Fig. 3](#F3){ref-type="fig"}, Panel D). On the other hand, HSL phosphorylation was only enhanced at HFD + 250 mg/kg *AfGAE* group compared to the HFD group in a treatment model ([Fig. 4](#F4){ref-type="fig"}, Panel D). And then, the p-HSL expression levels were reduced starting from 300 mg/kg of *AfGAE* showing no difference compared to that of HFD group in a treatment model. Lastly, ACC expression in mesenteric adipose tissue was not altered by *AfGAE* administration in both prevention and treatment models.

AfGAE administration improved anti-inflammatory cytokine production in prevention, not in treatment model
---------------------------------------------------------------------------------------------------------

*IL-10*, an anti-inflammatory cytokine, production was dose-dependently increased in epididymal adipose tissue of a preventive model by *AfGAE* administration except in the highest concentration of *AfGAE* (1,000 mg/kg) group (*P* \< 0.05) ([Fig. 3](#F3){ref-type="fig"}, Panel E). Adiponectin levels in the mesenteric adipose tissue were also increased by *AfGAE* administration in preventive model, however a dose-dependent manner was not observed (*P* \< 0.05). On the other hand, *AfGAE* administration in the treatment model did not promote the *IL-10* expression in epididymal adipose tissue in a dose-dependent manner. Only mice fed HFD + 250 and 1,000 mg/kg *AfGAE* group showed a significant increase of *IL-10* compared to HFD group whereas adiponectin production was not significantly altered by *AfGAE* administration in the treatment model.

DISCUSSION
==========

Prevalence of obesity has been increasing continuously, and the same phenomenon is true in South Korea, which exhibits 150% increased prevalence of obesity compared to that of a decade ago \[[@B18]\]. Obesity-induced chronic inflammation causes macrophage infiltration in adipose tissue and various inflammatory cytokine productions which consequently are involved in insulin resistance, type 2 diabetes, and cardiovascular diseases \[[@B19][@B20][@B21]\]. Therefore, it has been an active research area to screen functional foods and/or compounds that have an anti-obesity property. *GA*, *Gelidium amansii*, containing plenty of agar is known to have anti-obesity, antioxidant, and anticarcinogenic effects \[[@B9][@B11][@B12][@B13]\]. Thus, agar itself has been recognized as active principles used to treat obesity \[[@B22]\], whereas other potential bioactive compounds in *GA* were not studied intensively. In this current study, we therefore investigated the effects of agar-free GA extract (*AfGAE*) by using diet-induced obese C57BL/6J mouse model. First, a pilot study was carried out to evaluate effects of *AfGAE* in a diet-induced obese mouse model. In addition, to find out an optimal concentration and proper approach strategy of *AfGAE* for potential health beneficial effects in DIO model, we further studied effects of various doses of *AfGAE* by using preventive and treatment of *AfGAE* against obesity and its associated harmful consequences in an *in vivo* model.

*AfGAE* administration in the pilot experiment did not prevent HFD induced obesity in C57BL/6J mice, but appeared to significantly increase *IL-10* levels in epididymal adipose tissue compared to control group. Furthermore, an increase of HSL phosphorylation was observed by *AfGAE* administration to HFD fed C57BL/6M mice. Thus, *AfGAE* administration affected an increase of *IL-10* expression in epididymal adipose tissue; suggesting the anti-inflammatory effects of *AfGAE* may not be due to agar itself in C57BL/6J mice. Collectively, besides agar, other components in the *AfGAE* may play a role to regulate the anti-inflammatory effects that shall warrant future studies.

Unlike previous studies conducted in DIO mouse model with *GA* containing agar, this present study did not show anti-obesity effects of *AfGAE* suggesting that agar might be the responsible element for the anti-obesity effect of *GA*. Kang et al. \[[@B8]\] and Yang et al. \[[@B11]\] reported the inhibitory effects of *GA* with agar on adiposity in mice and rats, respectively. Kang et al. \[[@B8]\] showed the anti-obesity effects of *Gelidium amansii* ethanol-extracts in high-fat diet (45% calories from fat) fed C57BL/6 mice for 12 wks. Yang et al. \[[@B11]\] demonstrated that minced *GA* feeding improves plasma glucose and lipid profiles in high-fat diet fed streptozotocin nicotinamide-induced diabetic rats. A recent study by Kang et al. \[[@B23]\] also demonstrated the anti-obesity effect of *GA* extracts in obese mice that fed only a high fat diet (60% calories from fat) for 5 wks which was a similar experimental design as our Exp-2, a treatment model. Although there are various factors such as sample *GA* preparation method and solvents of *GA* (ethanol extract of *GA* vs. minced *GA*), types of animal models (drug-induced diabetic model vs. diet-induced obesity model), types of high-fat diet used (45% calories from fat vs. 60% calories from fat), duration of feeding periods and when to introduce *GA*, GAE administration indeed prevented and/or treated high-fat diet induced obesity in mice \[[@B8][@B23]\]. Furthermore, Maeda et al. \[[@B7]\] demonstrated that agar diet reduced body weight by maintaining reduced calorie intake in obese patients with impaired glucose tolerance and type 2 diabetes. However, those patients were also instructed moderated intensity exercise along with fixed portions of agar prepared in tasty ways. Thus, anti-obesity effects of *GA* observed in three animal models and human subjects mentioned above suggest that agar in *GA* plays a critical role to regulate weight management despite a difficulty to compare them directly.

Adiponectin is known to act as a positive regulator to improve insulin resistance and inflammation. For example, a decrease of TNF-α by inhibiting NF-kB caused an increase in adiponectin levels in rodents \[[@B24]\]. In this present study, adiponectin levels in mesenteric adipose tissue of mice fed HFD + *AfGAE* was significantly increased compared to that of mice fed HFD in a preventive model, *Exp-1* study. Alteration of adiponectin levels by *AfGAE* administration, however, was not observed in a treatment model, *Exp-2*. This discrepancy of results between *Exp-1* and *Exp-2* could be explained by the following; (1) timing to start *AfGAE* administration, (2) tissue-specificity of certain cytokine productions, and (3) different sensitivity of certain cytokine production by local inflammation vs. systemic inflammation due to aging.

*AfGAE* used in this present study, was hydrolyzed to remove agar. During the hydrolyzation process, reducing sugar contents in *GA* increased by 110% \[[@B1]\]. It showed that increased reducing sugar contents in *AfGAE* did not have impacts on anti-obesity effects in HFD-fed C57BL/6J mice. HSL, a lipase induced by either fasting or catecholamine secretion, mobilize the stored fats by hydrolyzing the first fatty acid from a triglyceride molecule, freeing a fatty acid and diglyceride \[[@B25]\]. A recent study reported a decrease of paraepididymal and perirenal fat tissues, blood triglyceride, and inflammatory cytokines such as adipocytokines, TNF-α and IL-6 in rats fed HFD + GA for 11 wks \[[@B11]\]. Furthermore, Park et al. demonstrated that fucoid, brown algae, induced lipolysis by enhancing HSL phosphorylation \[[@B26]\]. In the current study, HSL phosphorylation in mesenteric fat was significantly increased by *AfGAE* in a dose-dependent manner compared to that of mice fed HFD only in a prevention study, *Exp-1* (*P* \< 0.001), whereas this dose-dependency phenomenon was not observed in a treatment study, *Exp-2*. It is worthwhile to note that the preventive method for *AfGAE* might be a better way to approach the potential health benefits on lipolysis related factors.

Comparing *GA* with agar and without agar (*AfGAE*), the anti-inflammatory effects of *GAE* with or without agar might be not due to agar itself, but other bioactive compound(s) in them. Thus, it is assumed that other active compounds such as polyphenols of *GAE* besides agar may play an important role in regulating obesity \[[@B27]\]. However, the responsible compounds related to various potential health-beneficial effects of *GAE* are not yet clear. Therefore, it is suggested that further studies should be performed on the isolation and identification of the component in *GA*. Strengths of this study are (1) conducting a series of experiments step by step to investigate the potential effects of *AfGAE*, and (2) finding out a better approach for *AfGAE* to have its superior effects, whereas limitations of this study are (1) not being able to show the responsible compound in *AfGAE* for anti-inflammatory effect, and (2) only measuring the local anti-inflammation, *IL-10* and adiponectin in abdominal fat pads not the systemic (i.e., plasma) inflammation.

Collectively the current study demonstrated that *AfGAE* enhanced anti-inflammatory cytokine production in a diet-induced obese mouse model despite being obese. In addition, we could conclude that the anti-inflammatory effect is independent of agar in *GA*. Although future studies are required, the result suggests that *GA* may be a therapeutic tool to improve health conditions related to inflammation.
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![Design of *in vivo* experiments\
*Pilot*: male 8-wk old C57BL/6J mice were stabilized for 1 wk, followed by 5 wks of DIO induction by HFD, and then were fed either HFD or HFD + *AfGAE* (250 mg/kg of body weight) for 8 wks (n = 5/group); *Exp-1*. Preventive model of *AfGAE*: male 8-wk old C57BL/6J mice were stabilized (S) and acclimatized (A) for oral administration, followed by oral administration of different doses of *AfGAE* (0, 250, 300, 500, 1,000 mg/kg of body weight, n = 5/group) with HFD for 8 wks; *Exp-2*. Treatment model of *AfGAE*: male 8-wk old C57BL/6J mice were stabilized for 1 wk, followed by 5 wks of DIO induction by HFD including the acclimation period of oral administration, and then fed different doses of *AfGAE* (0, 250, 300, 500, 1,000 mg/kg, n = 5/group) for 8 wks.](nrp-12-479-g001){#F1}

![Effects of *Agar-free GAE (AfGAE)* administration regarding inflammation and lipolysis related factors in HFD fed C57BL/6J mice\
Data are represented as the mean ± SD (n = 5). Bars that do not share the same superscript are significantly different by *t*-test (*P* \< 0.05). Panel A & B; representative immunoblot analysis of lipolysis related proteins, ACC and pHSL/total HSL of mesenteric fat pad, Panel C & D; representative immunoblot analysis of anti-inflammatory cytokines, *IL-10* and adiponectin, in epididymal fat pad from mice fed HFD or HFD + *AfGAE*.](nrp-12-479-g002){#F2}

![Effects of *AfGAE* administration in a preventive model, *Exp-1*, on changes of metabolic parameters, lipolysis and inflammation-related proteins in mesenteric adipose tissue of HFD fed C57BL/6J mice\
Data are represented as mean ± SD (n = 5). Bars that do not share the same superscript are significantly different by ANOVA (*P* \< 0.05). Panel A--C: final body weight, brown adipose tissue (BAT) weight, and fat to muscle mass ratio, Panel D & E: Representative immunoblot analysis of lipolysis and inflammation-related proteins, phosphorylation levels of HSL, total ACC, *IL-10*, and adiponectin in mesenteric fat pad from mice fed HFD or HFD + various doses of *AfGAE* in a preventive model.](nrp-12-479-g003){#F3}

![Effects of *AfGAE* administration in a treatment model, *Exp-2*, on metabolic parameters, lipolysis and inflammation-related proteins in mesenteric adipose tissue of HFD fed C57BL/6J mice\
Data are represented as mean ± SD (n = 5). Bars that do not share the same superscript are significantly different by ANOVA (*P* \< 0.05). Panel A--C: final body weight, brown adipose tissue (BAT) weight, and fat to muscle mass ratio, Panel D & E: Representative immunoblot analysis of lipolysis and inflammation-related proteins, phosphorylation levels of HSL, total ACC, *IL-10*, and adiponectin in mesenteric fat pad from mice fed HFD or HFD + various doses of *AfGAE* in a treatment model.](nrp-12-479-g004){#F4}

###### Composition of *Gelidium amansii* (*GA*) extracts (*GAE*)
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###### Metabolic parameters in pilot experiment^1)^
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C57BL/6J mice were acclimated to oral administration and fed with HFD or HFD + agar-free GAE (*AfGAE*, 250 mg/kg) for 8 wks (n = 5/group).

^1)^ Data are presented as the mean ± SD (n = 5).

^2)^ Means in the same row indicated with an asterisk are significantly different by t-test (^\*^ *P* \< 0.05, ^\*\*^ *P* \< 0.01).

^3)^ FER (Food Efficiency Ratio) = body weight gain/feed intake during 8 wks of feeding.
